Skip to main content
Journal of Clinical Microbiology logoLink to Journal of Clinical Microbiology
. 1980 Oct;12(4):594–601. doi: 10.1128/jcm.12.4.594-601.1980

Quantification of arabinitol in serum by selected ion monitoring as a diagnostic technique in invasive candidiasis.

J Roboz, R Suzuki, J F Holland
PMCID: PMC273644  PMID: 6999025

Abstract

D-Arabinitol was identified by mass spectrometry as a metabolite of Candida albicans and Candida tropicalis. For quantification, serum was deproteinized with acetone, the supernatant was evaporated to dryness, the silyl derivative was formed, and a portion was injected into a combined gas chromatograph-mass spectrometer system. Erythritol or 2-deoxy-galactitol was the internal standard. The protonated molecular ions, obtained in chemical ionization with isobutane, were monitored. For 39 normal subjects the mean endogenous arabinitol concentration was 0.52 microgram/ml (standard deviation, +/- 0.34). An increment of 0.2 microgram of arabinitol per ml could be quantified. Of 11 cases with diagnosed invasive candidiasis, 9 had arabinitol levels > 1.2 microgram/ml (8 microM) in the range of 1.2 to 25.0 micrograms/ml; the remaining 2 cases had levels in the normal range. Six cases of diagnosed colonized candidiasis showed normal arabinitol levels.

Full text

PDF
594

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Barnett J. A. The utilization of sugars by yeasts. Adv Carbohydr Chem Biochem. 1976;32:125–234. doi: 10.1016/s0065-2318(08)60337-6. [DOI] [PubMed] [Google Scholar]
  2. Ketchel S. J., Rodriguez V. Acute infections in cancer patients. Semin Oncol. 1978 Jun;5(2):167–179. [PubMed] [Google Scholar]
  3. Kiehn T. E., Bernard E. M., Gold J. W., Armstrong D. Candidiasis: detection by gas-liquid chromatography of D-arabinitol, a fungal metabolite, in human serum. Science. 1979 Nov 2;206(4418):577–580. doi: 10.1126/science.493963. [DOI] [PubMed] [Google Scholar]
  4. Klein J. J., Watanakunakorn C. Hospital-acquired fungemia. Its natural course and clinical significance. Am J Med. 1979 Jul;67(1):51–58. doi: 10.1016/0002-9343(79)90073-1. [DOI] [PubMed] [Google Scholar]
  5. Levine A. S., Schimpff S. C., Graw R. G., Jr, Young R. C. Hematologic malignancies and other marrow failure states: progress in the management of complicating infections. Semin Hematol. 1974 Apr;11(2):141–202. [PubMed] [Google Scholar]
  6. Miller G. G., Witwer M. W., Braude A. I., Davis C. E. Rapid identification of Candida albicans septicemia in man by gas-liquid chromatography. J Clin Invest. 1974 Nov;54(5):1235–1240. doi: 10.1172/JCI107867. [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. Pitkänen E. The serum polyol pattern and the urinary polyol excretion in diabetic and in uremic patients. Clin Chim Acta. 1972 Apr;38(1):221–230. doi: 10.1016/0009-8981(72)90230-6. [DOI] [PubMed] [Google Scholar]
  8. Singer C., Kaplan M. H., Armstrong D. Bacteremia and fungemia complicating neoplastic disease. A study of 364 cases. Am J Med. 1977 May;62(5):731–742. doi: 10.1016/0002-9343(77)90876-2. [DOI] [PubMed] [Google Scholar]
  9. Weiner M. H., Yount W. J. Mannan antigenemia in the diagnosis of invasive Candida infections. J Clin Invest. 1976 Nov;58(5):1045–1053. doi: 10.1172/JCI108555. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from Journal of Clinical Microbiology are provided here courtesy of American Society for Microbiology (ASM)

RESOURCES